PELLEGRINO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 145
EU - Europa 123
AS - Asia 46
Totale 314
Nazione #
US - Stati Uniti d'America 143
IT - Italia 45
SE - Svezia 43
CN - Cina 22
SG - Singapore 22
RU - Federazione Russa 15
DE - Germania 7
FI - Finlandia 3
BE - Belgio 2
CA - Canada 2
CZ - Repubblica Ceca 2
IE - Irlanda 2
IN - India 2
FR - Francia 1
GB - Regno Unito 1
PL - Polonia 1
UA - Ucraina 1
Totale 314
Città #
Ashburn 28
New York 28
Milan 19
Shanghai 15
Singapore 13
Boardman 10
Lawrence 10
Princeton 10
Moscow 8
Los Angeles 4
Rome 4
Helsinki 3
Paderborn 3
Verona 3
Bethesda 2
Brussels 2
Dublin 2
Pune 2
Québec 2
Seattle 2
Vazzola 2
Bari 1
Borås 1
Chicago 1
Crotone 1
Dalmine 1
Freiburg im Breisgau 1
Gaithersburg 1
Kunming 1
London 1
Lucca 1
Padova 1
San Antonio 1
Santa Clara 1
Segrate 1
Totale 186
Nome #
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 34
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 29
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 25
How to Select the Optimal Candidates for Renal Mass Biopsy 25
Neoadjuvant and adjuvant immunotherapy in renal cell carcinoma 23
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 21
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 21
Reply by Authors 20
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 18
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 17
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy 17
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 17
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 16
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 13
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve 11
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 10
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 9
Noninvasive detection of any-stage cancer using free glycosaminoglycans 9
Reply to: Antonio Andrea Grosso, Agostino Tuccio, Matteo Salvi, Daniele Paganelli, Andrea Minervini, and Fabrizio Di Maida's Letter to the Editor re: Paolo Capogrosso, Eugenio Ventimiglia, Giuseppe Fallara, et al. Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.03.018 8
null 1
Totale 344
Categoria #
all - tutte 3.563
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.563


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2021/202221 0 5 1 6 0 2 1 2 0 0 0 4
2022/202388 25 18 5 2 2 9 4 14 1 0 4 4
2023/2024192 4 11 19 15 17 47 3 20 0 27 14 15
2024/202542 42 0 0 0 0 0 0 0 0 0 0 0
Totale 344